Clinical Trials Browser

Phase 3 × Recruiting × mirvetuximab soravtansine × Clear all

NCT05445778 2026-02-23

GLORIOSA

Phase 3 Recruiting

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT07218809 2026-01-16

TREVI-OC-01

Phase 3 Recruiting

Carcinoma, Ovarian Epithelial